13F-HR filed by Altium Capital Management LLC
Altium Capital Management LLC filed this 13F-HR for the quarter ended 2024-09-30, filed 2024-11-14, with 79 holding rows worth $339,708,332.
- Accession
- 0001420506-24-002530
- Filer
- CIK 1746382
- Filed
- 2024-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2024
A holdings report, 79 entries on the cover page, a total value of $339,708,332 stated on the cover page (in dollars after the unit check, H1), rows summing to $339,708,332 with VALUE read as dollars as filed, 13F file number 028-20820. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 684,000 | $30,232,800 | dollars as filed | |
| ADMA BIOLOGICS INC | 000899104 | COM | 1,360,000 | $27,186,400 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 170,000 | $21,231,300 | dollars as filed | |
| EDWARDS LIFESCIENCES CORP COM | 28176E108 | Stock | 222,000 | $14,649,780 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 360,600 | $14,196,822 | dollars as filed | |
| ZEVRA THERAPEUTICS INC COM NEW | 488445206 | Stock | 1,700,000 | $11,798,000 | dollars as filed | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 154,000 | $11,268,180 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 212,909 | $10,749,775 | dollars as filed | |
| GLAUKOS CORP COM | 377322102 | Stock | 77,000 | $10,031,560 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 130,000 | $9,490,000 | dollars as filed | |
| MERIT MED SYS INC COM | 589889104 | Stock | 85,000 | $8,400,550 | dollars as filed | |
| REZOLUTE INC | 76200L309 | COMMON STOCK | 1,700,000 | $8,245,000 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 72,000 | $8,227,440 | dollars as filed | |
| AVADEL PHARMACEUTICALS PLC | G29687103 | COM SHS | 610,000 | $8,000,150 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 126,000 | $7,977,060 | dollars as filed | |
| CATALYST PHARMACEUTICALS INC | 14888U101 | COM | 385,000 | $7,653,800 | dollars as filed | |
| CONTINEUM THERAPEUTICS INC CL A | 21217B100 | Stock | 369,126 | $7,065,072 | dollars as filed | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 355,000 | $6,876,350 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 1,575,000 | $6,678,000 | dollars as filed | |
| IRHYTHM HOLDINGS INC COM | 450056106 | Stock | 86,000 | $6,384,640 | dollars as filed | |
| EVOLUS INC | 30052C107 | COM | 355,000 | $5,751,000 | dollars as filed | |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 131,000 | $5,668,370 | dollars as filed | |
| RXSIGHT INC | 78349D107 | COM | 112,000 | $5,536,160 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 58,000 | $5,212,460 | dollars as filed | |
| SKYE BIOSCIENCE INC | 83086J200 | COM NEW | 1,315,146 | $5,142,221 | dollars as filed | |
| XTANT MED HLDGS INC | 98420P308 | COM NEW | 7,415,413 | $5,012,819 | dollars as filed | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 693,000 | $4,539,150 | dollars as filed | |
| CAPRICOR THERAPEUTICS INC | 14070B309 | COMMON STOCK | 285,000 | $4,334,850 | dollars as filed | |
| PULMONX CORP | 745848101 | COM | 500,000 | $4,145,000 | dollars as filed | |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 195,000 | $4,022,850 | dollars as filed | |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 69,000 | $4,006,830 | dollars as filed | |
| THE REALREAL INC | 88339P101 | COM | 1,270,000 | $3,987,800 | dollars as filed | |
| PERSPECTIVE THERAPEUTICS INC | 46489V302 | COMMON STOCK | 290,000 | $3,871,500 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 75,000 | $3,747,750 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 355,000 | $3,638,750 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 70,000 | $3,072,300 | dollars as filed | |
| OUTLOOK THERAPEUTICS INC | 69012T305 | COM | 541,549 | $2,891,872 | dollars as filed | |
| VERICEL CORP | 92346J108 | COM | 68,000 | $2,873,000 | dollars as filed | |
| CYBIN INC | 23256X407 | COM NEW | 317,000 | $2,818,130 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 330,000 | $2,752,200 | dollars as filed | |
| OCUGEN INC | 67577C105 | COMMON STOCK | 2,350,000 | $2,331,670 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 40,000 | $2,016,800 | dollars as filed | |
| BICYCLE THERAPEUTICS PLC-ADR | 088786108 | SPONSORED ADS | 85,000 | $1,923,550 | dollars as filed | |
| ANNOVIS BIO INC | 03615A108 | COM | 236,400 | $1,905,384 | dollars as filed | put |
| Veru Inc | 92536C103 | Common Stock | 2,028,534 | $1,559,943 | dollars as filed | |
| ATRICURE INC | 04963C209 | COM | 54,000 | $1,514,160 | dollars as filed | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 196,000 | $1,283,800 | dollars as filed | call |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 915,000 | $1,079,700 | dollars as filed | |
| ENVVENO MEDICAL CORPORATION | 29415J106 | COM | 238,920 | $802,771 | dollars as filed | |
| Tempest Therapeutics, Inc. | 87978U108 | Common Stock | 545,000 | $763,000 | dollars as filed | |
| PROMIS NEUROSCIENCES INC | 74346M406 | COM NEW | 581,395 | $726,744 | dollars as filed | |
| Milestone Pharmaceuticals Inc | 59935V107 | COM | 440,000 | $668,800 | dollars as filed | |
| KARYOPHARM THERAPEUTICS INC | 48576U106 | COM | 740,000 | $614,200 | dollars as filed | |
| UNICYCIVE THERAPEUTICS INC | 90466Y103 | CMN | 1,473,000 | $600,837 | dollars as filed | |
| FAT BRANDS INC | 30258N121 | *W EXP 07/16/202 | 200,000 | $499,000 | dollars as filed | |
| Applied Therapeutics Inc | 03828A101 | Common Stock | 56,100 | $476,850 | dollars as filed | put |
| CELLECTAR BIOSCIENCES INC | 15117F807 | COM | 215,000 | $460,100 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 9,400 | $370,078 | dollars as filed | call |
| SRX GLOBAL INC | 08771Y402 | COM NEW | 133,117 | $278,215 | dollars as filed | |
| EXPION360 INC | 30218B100 | COM | 2,057,494 | $106,372 | dollars as filed | |
| NEXGEL INC | 65344E115 | *W EXP 12/27/202 | 225,000 | $91,474 | dollars as filed | |
| Scorpius Holdings Inc | 42237K508 | COM | 88,291 | $63,570 | dollars as filed | |
| Rocket Pharmaceuticals Inc W Exp 09/02/202 | 77313F114 | Warrant | 731,561 | $51,209 | dollars as filed | |
| ONFOLIO HOLDINGS INC | 68277K124 | *W EXP 01/02/202 | 200,000 | $34,000 | dollars as filed | |
| WEARABLE DEVICES LTD | M97838110 | *W EXP 09/14/202 | 1,411,600 | $28,091 | dollars as filed | |
| MOBIX LABS INC | 60743G118 | *W EXP 12/21/202 | 150,000 | $22,320 | dollars as filed | |
| Cingulate Inc W Exp 12/10/202 | 17248W113 | Warrant | 270,000 | $18,684 | dollars as filed | |
| NEKTAR THERAPEUTICS | 640268108 | COM | 11,419 | $14,845 | dollars as filed | |
| NEXALIN TECHNOLOGY INC | 65345B110 | *W EXP 99/99/999 | 105,000 | $8,400 | dollars as filed | |
| CEA INDUSTRIES INC | 86887P119 | *W EXP 02/11/202 | 250,000 | $6,275 | dollars as filed | |
| Vsee Health Inc W Exp 99/99/999 | 92919Y110 | SPAC Combination | 150,000 | $6,000 | dollars as filed | |
| BITCOIN DEPOT INC | 09174P113 | *W EXP 06/30/202 | 50,000 | $2,495 | dollars as filed | |
| NEXERA TECHNOLOGIES LTD | M61472110 | *W EXP 08/26/202 | 68,681 | $2,445 | dollars as filed | |
| NLS PHARMACEUTICS LTD | H57830111 | *W EXP 02/02/202 | 200,000 | $2,280 | dollars as filed | |
| CYCURION INC | 95758L115 | *W EXP 02/13/203 | 100,000 | $2,180 | dollars as filed | |
| Cdt Equity Inc W Exp 09/22/202 | 20678X114 | SPAC Combination | 100,000 | $1,595 | dollars as filed | |
| COLISEUM ACQUISITION CORP | G2263T107 | *W EXP 08/22/202 | 28,333 | $1,417 | dollars as filed | |
| SURROZEN INC | 86889P117 | *W EXP 08/01/203 | 82,233 | $1,044 | dollars as filed | |
| TC BIOPHARM HOLDINGS PLC | 87807D111 | *W EXP 02/10/202 | 18,823 | $343 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-24-002530 | this filing | 2024-11-14 | acceptance time not in the bulk data set |